Citius Pharmaceuticals (CTXR) Stock Chart & Stock Price History → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free CTXR Stock Alerts $0.82 +0.07 (+8.86%) (As of 05:27 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Citius Pharmaceuticals Stock Price Performance5 Day Performance+0.19%1 Month Performance+7.18%3 Month Performance+3.15%6 Month Performance+7.52%Year-To-Date Performance+4.34%1 Year Performance-52.16% Receive CTXR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad DTIThis company has increased its dividend every year for 54 yearsThere are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.Click here to get them (for Free). CTXR Stock Chart for Wednesday, April, 17, 2024 CTXR Chart by TradingView Citius Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/16/2024$0.77$0.75-2.01%$0.76$0.73482,635 shs$119.29 million04/15/2024$0.79$0.77-2.87%$0.79$0.75724,923 shs$121.74 million04/12/2024$0.83$0.79-5.45%$0.83$0.78625,548 shs$125.34 million04/11/2024$0.85$0.83-2.00%$0.89$0.70876,345 shs$132.56 million04/10/2024$0.89$0.85-4.50%$0.88$0.83828,642 shs$135.27 million04/09/2024$0.96$0.89-7.36%$0.97$0.86888,899 shs$141.65 million Get the Latest News and Ratings for CTXR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/08/2024$1.00$0.96-3.84%$1.00$0.95513,187 shs$152.90 million04/05/2024$0.95$1.00+5.40%$1.02$0.90921,431 shs$159.01 million04/04/2024$0.96$0.95-1.73%$0.99$0.921.48 million shs$150.86 million04/03/2024$0.98$0.96-1.20%$1.01$0.96964,613 shs$153.52 million04/02/2024$1.03$0.98-5.18%$1.07$0.931.72 million shs$155.38 million04/01/2024$0.90$1.03+14.79%$1.07$0.911.79 million shs$163.87 million03/29/2024$0.90$0.90$0.93$0.811.28 million shs$142.76 million03/28/2024$0.82$0.90+8.88%$0.93$0.811.28 million shs$142.76 million03/27/2024$0.80$0.82+2.82%$0.83$0.78460,219 shs$131.11 million03/26/2024$0.80$0.80-0.06%$0.82$0.78565,107 shs$127.52 million03/25/2024$0.79$0.80+1.75%$0.84$0.78803,417 shs$127.60 million03/22/2024$0.75$0.79+5.05%$0.79$0.72705,553 shs$125.40 million03/21/2024$0.78$0.75-3.32%$0.78$0.74570,644 shs$119.37 million03/20/2024$0.74$0.78+4.47%$0.78$0.73470,272 shs$123.48 million03/19/2024$0.72$0.74+3.15%$0.75$0.72425,294 shs$118.20 million03/18/2024$0.74$0.72-2.20%$0.80$0.701.09 million shs$114.58 million03/15/2024$0.69$0.74+6.91%$0.74$0.681.61 million shs$117.16 million03/14/2024$0.72$0.69-4.37%$0.73$0.68544,542 shs$109.59 million03/13/2024$0.69$0.72+3.74%$0.73$0.71380,803 shs$114.60 million03/12/2024$0.72$0.69-3.57%$0.74$0.65871,763 shs$110.46 million03/11/2024$0.75$0.72-3.56%$0.75$0.72305,741 shs$114.55 million03/08/2024$0.75$0.75+0.08%$0.78$0.73432,065 shs$118.78 million03/07/2024$0.72$0.75+4.34%$0.75$0.72308,561 shs$118.69 million03/06/2024$0.73$0.72-2.20%$0.77$0.70516,591 shs$113.76 million03/05/2024$0.77$0.73-4.53%$0.78$0.73577,924 shs$116.32 million03/04/2024$0.78$0.77-1.49%$0.80$0.76314,533 shs$121.84 million03/01/2024$0.77$0.78+1.18%$0.80$0.76319,259 shs$123.68 million02/29/2024$0.79$0.77-2.23%$0.82$0.76438,332 shs$122.24 million02/28/2024$0.75$0.79+4.30%$0.80$0.75428,961 shs$125.02 million02/27/2024$0.74$0.75+1.67%$0.76$0.74413,658 shs$119.87 million02/26/2024$0.76$0.74-2.50%$0.80$0.74540,829 shs$117.89 million02/23/2024$0.79$0.76-3.80%$0.79$0.76414,174 shs$120.92 million02/22/2024$0.77$0.79+2.61%$0.80$0.76396,104 shs$125.69 million02/21/2024$0.75$0.77+2.65%$0.78$0.74388,901 shs$122.49 millionBitcoin Rockets To Record High But Buy THIS Instead (Ad)Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is.02/20/2024$0.80$0.75-5.67%$0.78$0.73868,520 shs$119.33 million02/19/2024$0.80$0.80$0.86$0.771.22 million shs$126.50 million02/16/2024$0.84$0.80-5.60%$0.86$0.771.22 million shs$126.40 million02/15/2024$0.77$0.84+9.12%$0.84$0.761.04 million shs$133.90 million02/14/2024$0.68$0.77+13.51%$0.78$0.711.03 million shs$122.71 million02/13/2024$0.72$0.68-5.12%$0.74$0.67778,191 shs$108.10 million02/12/2024$0.66$0.72+8.92%$0.74$0.631.13 million shs$113.93 million02/09/2024$0.61$0.66+7.57%$0.67$0.60560,618 shs$104.60 million02/08/2024$0.61$0.61$0.63$0.61578,003 shs$97.24 million02/07/2024$0.61$0.61+0.23%$0.64$0.60564,287 shs$97.24 million02/06/2024$0.60$0.61+1.72%$0.62$0.60687,979 shs$97.02 million02/05/2024$0.63$0.60-4.09%$0.65$0.60672,014 shs$95.38 million02/02/2024$0.64$0.63-1.76%$0.65$0.62346,199 shs$99.45 million02/01/2024$0.62$0.64+2.54%$0.65$0.62619,972 shs$101.23 million01/31/2024$0.63$0.62-0.64%$0.64$0.62433,367 shs$98.72 million01/30/2024$0.67$0.63-6.54%$0.72$0.62796,436 shs$99.36 million01/29/2024$0.68$0.67-1.69%$0.72$0.651.49 million shs$106.30 million01/26/2024$0.65$0.68+4.15%$0.69$0.66308,149 shs$108.13 million01/25/2024$0.64$0.65+2.03%$0.68$0.63510,175 shs$103.82 million01/24/2024$0.67$0.64-4.97%$0.68$0.611.40 million shs$101.76 million01/23/2024$0.70$0.67-3.77%$0.71$0.66793,637 shs$107.08 million01/22/2024$0.72$0.70-2.91%$0.74$0.67924,995 shs$111.28 million01/19/2024$0.75$0.72-3.87%$0.76$0.72675,552 shs$114.62 million01/18/2024$0.77$0.75-1.99%$0.79$0.741.39 million shs$119.23 million01/17/2024$0.75$0.77+2.03%$0.78$0.74850,098 shs$121.64 million01/16/2024$0.75$0.75$0.76$0.74433,298 shs$119.23 million Related Companies: COYA Stock Chart SCTL Stock Chart OPTN Stock Chart IMUX Stock Chart RPTX Stock Chart ADAG Stock Chart NVCT Stock Chart VTGN Stock Chart CTMX Stock Chart ELYM Stock Chart Receive CTXR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CTXR) was last updated on 4/17/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchYour Money is Not SafeAmerican AlternativeTop 5 AI Stocks to Buy for 2024Market Moving TrendsOptions trading has suddenly become more reliable.Eagle PublishingTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Citius Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.